Discover
MANE
Veradermics, Incorporated
114.39
1 x 91.35
1 x 157.39
bid
ask
+
5.74
5.28%
1 @ 04:00 PM
116.00 +1.61 (1.41%)
| Ytd | 203.02% | |
| 1y | 203.02% |
109.89
day range
114.40
37.03
52 week range
129.74
| Open | 110.68 | Prev Close | 108.65 | Low | 109.89 | High | 114.40 | Mkt Cap | 4.78B |
| Vol | 541.27K | Avg Vol | 662.16K | EPS | -3.14 | P/E | -36.42 | Forward P/E | -39.37 |
| Beta | N/A | Short Ratio | 5.22 | Inst. Own | 80.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 107.50 | 200-d Avg | 83.78 | 1yr Est | 163.50 |
| Income Statement | |||
| Operating Expenses | 29.86M | ||
| Research and Development Expense | 20.93M | ||
| Selling, General and Administrative Expense | 8.94M | ||
| Operating Income | -29.86M | ||
| Net Income | -30.01M | ||
| Net Income Common Stock | -30.01M | ||
| Net Income Common Stock (USD) | -30.01M | ||
| Consolidated Income | -27.23M | ||
| Net Income to Non-Controlling Interests | 2.78M | ||
| Earnings per Basic Share | -1.32 | ||
| Earnings per Basic Share (USD) | -1.32 | ||
| Earnings per Diluted Share | -1.32 | ||
| Earning Before Interest & Taxes (EBIT) | -30.01M | ||
| Earning Before Interest & Taxes (USD) | -30.01M | ||
| Weighted Average Shares | 22.70M | ||
| Weighted Average Shares Diluted | 22.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 168.41M | ||
| Cash and Equivalents (USD) | 168.41M | ||
| Investments | 222.39M | ||
| Investments Current | 222.39M | ||
| Current Assets | 397.07M | ||
| Property, Plant & Equipment Net | 287.00K | ||
| Total Assets | 397.36M | ||
| Current Liabilities | 6.72M | ||
| Total Liabilities | 6.72M | ||
| Accumulated Retained Earnings (Deficit) | -150.65M | ||
| Accumulated Other Comprehensive Income | -524.00K | ||
| Shareholders Equity | 390.64M | ||
| Shareholders Equity (USD) | 390.64M | ||
| Assets Non-Current | 287.00K | ||
| Trade and Non-Trade Payables | 1.07M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 269.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 146.65M | ||
| Issuance (Purchase) of Equity Shares | 269.11M | ||
| Net Cash Flow from Investing | -101.30M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -101.30M | ||
| Net Cash Flow from Operations | -21.17M | ||
| Share Based Compensation | 5.26M | ||